Literature DB >> 11003670

RB-dependent S-phase response to DNA damage.

K E Knudsen1, D Booth, S Naderi, Z Sever-Chroneos, A F Fribourg, I C Hunton, J R Feramisco, J Y Wang, E S Knudsen.   

Abstract

The retinoblastoma tumor suppressor protein (RB) is a potent inhibitor of cell proliferation. RB is expressed throughout the cell cycle, but its antiproliferative activity is neutralized by phosphorylation during the G(1)/S transition. RB plays an essential role in the G(1) arrest induced by a variety of growth inhibitory signals. In this report, RB is shown to also be required for an intra-S-phase response to DNA damage. Treatment with cisplatin, etoposide, or mitomycin C inhibited S-phase progression in Rb(+/+) but not in Rb(-/-) mouse embryo fibroblasts. Dephosphorylation of RB in S-phase cells temporally preceded the inhibition of DNA synthesis. This S-phase dephosphorylation of RB and subsequent inhibition of DNA replication was observed in p21(Cip1)-deficient cells. The induction of the RB-dependent intra-S-phase arrest persisted for days and correlated with a protection against DNA damage-induced cell death. These results demonstrate that RB plays a protective role in response to genotoxic stress by inhibiting cell cycle progression in G(1) and in S phase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003670      PMCID: PMC86358          DOI: 10.1128/MCB.20.20.7751-7763.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.

Authors:  M W Strobeck; A F Fribourg; A Puga; E S Knudsen
Journal:  Oncogene       Date:  2000-04-06       Impact factor: 9.867

2.  Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.

Authors:  M J Tilby; C Johnson; R J Knox; J Cordell; J J Roberts; C J Dean
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

3.  Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.

Authors:  H S Zhang; M Gavin; A Dahiya; A A Postigo; D Ma; R X Luo; J W Harbour; D C Dean
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

4.  Specific enzymatic dephosphorylation of the retinoblastoma protein.

Authors:  J W Ludlow; C L Glendening; D M Livingston; J A DeCarprio
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

5.  Radiosensitivity in ataxia-telangiectasia: a new explanation.

Authors:  R B Painter; B R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  Unscheduled DNA synthesis in cultured ataxia telangiectasia fibroblast-like cells.

Authors:  R A Vincent; A J Fink; P C Huang
Journal:  Mutat Res       Date:  1980-09       Impact factor: 2.433

7.  BRG-1 is required for RB-mediated cell cycle arrest.

Authors:  M W Strobeck; K E Knudsen; A F Fribourg; M F DeCristofaro; B E Weissman; A N Imbalzano; E S Knudsen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

8.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae.

Authors:  T A Weinert; L H Hartwell
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

9.  Hypoxic stress induces reversible hypophosphorylation of pRB and reduction in cyclin A abundance independent of cell cycle progression.

Authors:  J W Ludlow; R L Howell; H C Smith
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

10.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  86 in total

1.  Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Authors:  Z Sever-Chroneos; S P Angus; A F Fribourg; H Wan; I Todorov; K E Knudsen; E S Knudsen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice.

Authors:  Alain de Bruin; Lizhao Wu; Harold I Saavedra; Pamela Wilson; Ying Yang; Thomas J Rosol; Michael Weinstein; Michael L Robinson; Gustavo Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

3.  RB reversibly inhibits DNA replication via two temporally distinct mechanisms.

Authors:  Steven P Angus; Christopher N Mayhew; David A Solomon; Wesley A Braden; Michael P Markey; Yukiko Okuno; M Cristina Cardoso; David M Gilbert; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

4.  DNA damage signals through differentially modified E2F1 molecules to induce apoptosis.

Authors:  Jasmyne Carnevale; Oliva Palander; Laurie A Seifried; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

5.  PNUTS knockdown potentiates the apoptotic effect of Roscovitine in breast and colon cancer cells.

Authors:  Gabriel De Leon; Margaret Cavino; Mikilyn D'Angelo; Nancy A Krucher
Journal:  Int J Oncol       Date:  2010-05       Impact factor: 5.650

6.  cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA.

Authors:  Soheil Naderi; Jean Y J Wang; Tung-Ti Chen; Kristine B Gutzkow; Heidi K Blomhoff
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

7.  Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage.

Authors:  Yasumichi Inoue; Masatoshi Kitagawa; Yoichi Taya
Journal:  EMBO J       Date:  2007-03-22       Impact factor: 11.598

Review 8.  RB: mitotic implications of a tumour suppressor.

Authors:  Amity L Manning; Nicholas J Dyson
Journal:  Nat Rev Cancer       Date:  2012-02-09       Impact factor: 60.716

9.  Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation.

Authors:  Alessandra Magenta; Pasquale Fasanaro; Sveva Romani; Valeria Di Stefano; Maurizio C Capogrossi; Fabio Martelli
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

Review 10.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.